HBK Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,646,637
Closed -$777M 364
2025
Q4
$777M Buy
+7,646,637
New +$614M 6.1% 3
2021
Q3
Sell
-7,325
Closed -$773K 792
2021
Q2
$911K Buy
7,325
+2,755
+60% +$329K ﹤0.01% 591
2021
Q1
$602K Buy
+4,570
New +$626K ﹤0.01% 645
2018
Q3
Sell
-33,524
Closed -$2M 1212
2018
Q2
$2M Buy
+33,524
New +$1.8M 0.01% 486
2017
Q3
Sell
-23,286
Closed -$824K 1041
2017
Q2
$824K Buy
+23,286
New +$719K 0.01% 620
2016
Q4
Sell
-72,100
Closed -$1.34M 776
2016
Q3
$1.34M Buy
+72,100
New +$1.27M 0.01% 450
2013
Q4
Sell
-12,900
Closed -$152K 930
2013
Q3
$152K Buy
+12,900
New +$166K ﹤0.01% 838

Other funds holding EXAS

HBK Investments's EXAS Position: Q1 2026 in Review

HBK Investments sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 7,646,637 shares — an estimated $777M sold.

HBK Investments first reported a position in EXAS in Q3 2013 and held it in 7 quarters. The position peaked at $777M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • HBK Investments reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • HBK Investments sold 7,646,637 Exact Sciences shares in Q1 2026, an estimated $777M.
  • HBK Investments first reported a position in Exact Sciences in Q3 2013 and held it in 7 quarters.
  • HBK Investments's Exact Sciences position peaked at $777M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on HBK Investments's 13F filing for Q1 2026, filed 15 May 2026.